Announced Wed, 15 Jul · 15:24 IST
Biocon FY26 Annual Report and 48th AGM notice filed
Board & Shareholder Meetings View source PDF
BIOCON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.1%1-day move
₹437.00
prior close
₹434.70
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+1.1-0.1-0.2+0.8+0.3-0.8————
Up moveDown movePending
AI summary
Biocon filed its Integrated Annual Report for FY26 and notice for the 48th AGM on August 6, 2026 at 3:30 PM via video conferencing. Total income grew 14% to Rs 172,695 million (USD 1.96 billion). Biosimilars grew 16% to USD 1.18 billion, Generics 17%, CRDMO 3%. EBITDA rose 25% to Rs 37,978 million, margin 22%. Net profit was Rs 3,856 million, EPS Rs 2.82. Final dividend of Rs 0.50 per share declared. Biocon Biologics fully merged into Biocon.
Likely market impact
Shareholders can vote electronically from August 1-5, 2026. Final dividend of Rs 0.50 per share with record date July 3, 2026. AGM on August 6.